Development of human thioredoxin as a mucolytic therapy for cystic fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R43HL114132
- Recipient
-
Orpro Therapeutics Inc. UEI DMFYKL5PQLF3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $183,089
Award facts
- Assistance listing
- 93.838 Lung Diseases Research
- Completion date
- Place of performance
- San Diego, CA 92131, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43HL114132?
R43HL114132 was awarded to Orpro Therapeutics Inc. by National Institutes of Health (Department of Health and Human Services) on August 1, 2012.
How much is award R43HL114132 worth?
$183,089 has been obligated on R43HL114132.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award